Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deepak L Bhatt

Showing results (731-740 of 1,708) with videos related to

Pageof 171
Sort By:
American Heart Journal|October 11, 2011
Improvement in use of anticoagulation therapy in patients with ischemic stroke: results from Get With The Guidelines-StrokeWilliam R Lewis, Gregg C Fonarow, Maria V Grau-Sepulveda, et al.
Stroke|July 3, 2010
Effect of clopidogrel on the rate and functional severity of stroke among high vascular risk patients: a prespecified substudy of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA) trialGraeme J Hankey, Werner Hacke, J Donald Easton, et al.
The New England Journal of Medicine|October 29, 2010
Effects of CYP2C19 genotype on outcomes of clopidogrel treatmentGuillaume Paré, Shamir R Mehta, Salim Yusuf, et al.
Journal of the American College of Cardiology|September 24, 2013
Patient and hospital characteristics associated with inappropriate percutaneous coronary interventionsPaul S Chan, Sunil V Rao, Deepak L Bhatt, et al.
Circulation. Cardiovascular Quality and Outcomes|September 25, 2014
Chronic kidney disease and bleeding complications after intravenous thrombolytic therapy for acute ischemic strokeBruce Ovbiagele, Eric E Smith, Lee H Schwamm, et al.
JAMA Cardiology|March 27, 2020
Enrollment of Older Patients, Women, and Racial/Ethnic Minority Groups in Contemporary Acute Coronary Syndrome Clinical Trials: A Systematic ReviewAyman Samman Tahhan, Muthiah Vaduganathan, Stephen J Greene, et al.
The American Journal of Cardiology|October 21, 2018
Usefulness of Rivaroxaban for Secondary Prevention of Acute Coronary Syndrome in Patients With History of Congestive Heart Failure (from the ATLAS-ACS-2 TIMI-51 Trial)Serge Korjian, Eugene Braunwald, Yazan Daaboul, et al.
Diabetes, Obesity & Metabolism|May 7, 2020
The effect of glucagon-like peptide-1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across baseline blood pressure categories: Analysis of the LEADER and SUSTAIN 6 trialsLawrence A Leiter, Stephen C Bain, Deepak L Bhatt, et al.
Journal of the American Heart Association|June 7, 2014
Patterns of care quality and prognosis among hospitalized ischemic stroke patients with chronic kidney diseaseBruce Ovbiagele, Lee H Schwamm, Eric E Smith, et al.
Heart Failure Reviews|May 3, 2025
Obesity and inflammation in chronic and acute heart failureGad Cotter, Mark C Petrie, Javed Butler, et al.
Pageof 171

Showing results (731-740 of 1,708) with videos related to

Sort By:
Pageof 171
American Heart Journal|October 11, 2011
Improvement in use of anticoagulation therapy in patients with ischemic stroke: results from Get With The Guidelines-StrokeWilliam R Lewis, Gregg C Fonarow, Maria V Grau-Sepulveda, et al.
Stroke|July 3, 2010
Effect of clopidogrel on the rate and functional severity of stroke among high vascular risk patients: a prespecified substudy of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA) trialGraeme J Hankey, Werner Hacke, J Donald Easton, et al.
The New England Journal of Medicine|October 29, 2010
Effects of CYP2C19 genotype on outcomes of clopidogrel treatmentGuillaume Paré, Shamir R Mehta, Salim Yusuf, et al.
Journal of the American College of Cardiology|September 24, 2013
Patient and hospital characteristics associated with inappropriate percutaneous coronary interventionsPaul S Chan, Sunil V Rao, Deepak L Bhatt, et al.
Circulation. Cardiovascular Quality and Outcomes|September 25, 2014
Chronic kidney disease and bleeding complications after intravenous thrombolytic therapy for acute ischemic strokeBruce Ovbiagele, Eric E Smith, Lee H Schwamm, et al.
JAMA Cardiology|March 27, 2020
Enrollment of Older Patients, Women, and Racial/Ethnic Minority Groups in Contemporary Acute Coronary Syndrome Clinical Trials: A Systematic ReviewAyman Samman Tahhan, Muthiah Vaduganathan, Stephen J Greene, et al.
The American Journal of Cardiology|October 21, 2018
Usefulness of Rivaroxaban for Secondary Prevention of Acute Coronary Syndrome in Patients With History of Congestive Heart Failure (from the ATLAS-ACS-2 TIMI-51 Trial)Serge Korjian, Eugene Braunwald, Yazan Daaboul, et al.
Diabetes, Obesity & Metabolism|May 7, 2020
The effect of glucagon-like peptide-1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across baseline blood pressure categories: Analysis of the LEADER and SUSTAIN 6 trialsLawrence A Leiter, Stephen C Bain, Deepak L Bhatt, et al.
Journal of the American Heart Association|June 7, 2014
Patterns of care quality and prognosis among hospitalized ischemic stroke patients with chronic kidney diseaseBruce Ovbiagele, Lee H Schwamm, Eric E Smith, et al.
Heart Failure Reviews|May 3, 2025
Obesity and inflammation in chronic and acute heart failureGad Cotter, Mark C Petrie, Javed Butler, et al.
Pageof 171